Precision Nanorobotics for Early Diagnosis of Chronic and Oncological Diseases: A Multimodal Approach to Arthritis, Asthma, Tumor?s, And Fatty Liver

References

[1] Drexler, K. E. (1986). Engines of creation: The coming era of nanotechnology. Anchor Books.

[2] Kurzweil, R. (2005). The singularity is near: When humans transcend biology. Viking Press.

[3] Allhoff, F., Lin, P., Moor, J., & Weckert, J. (2010). Nanoethics: The ethical and social implications of nanotechnology. Wiley.

[4] Park, B.-W., Zhuang, J., Yasa, O., & Sitti, M. (2017). Multifunctional micro-swimmers for targeted stem cell delivery. Science Robotics, 2(7), eaah3780. https://

[5] Xu, T., Yu, J., Yan, X., Choi, H., & Zhang, L. (2019). Magnetically propelled fish-like nanoswimmers for targeted drug delivery. Science Advances, 5(10), eaav4803. https://

[6] Sitti, M. (2009). Mobile microrobotics. Annual Review of Biomedical Engineering, 11, 85–106. https:// 07.160535

[7] Yin, P., Hariadi, R. F., Sahu, S., Choi, H. M. T., Park, S. H., LaBean, T. H., & Reif, J. H. (2008). Programming DNA tube circumferences. Science, 321(5890), 824 –826. https://

[8] Douglas, S. M., Bachelet, I., & Church, G. M. (2012). A logic-gated nanorobot for targeted transport of molecular payloads. Science, 335(6070), 831 –834. https://

[9] Linko, V., & Dietz, H. (2013). The enabled state of DNA nanotechnology. Current Opinion in Biotechnology, 24(4), 555 –561. https://

[10] Sun, W., Ji, W., Hall, J. M., Hu, Q., Wang, C., Beisel, C. L., & Gu, Z. (2018). Self-assembled DNA nanocages for encapsulation and delivery of biomolecules. Nature Biotechnology, 36(4), 351–359. https://

[11] Shao, J., Li, Y., Huang, W., Xu, Y., Liu, Y., Xiao, F., & Dong, X. (2022). Biohybrid micro- and nanorobots for intelligent drug delivery. Cyborg and Bionic Systems, 2022, 9824057. https://

[12] Li, J., Esteban-Fernández de Ávila, B., Gao, W., Zhang, L., & Wang, J. (2021). Micro/nanorobots for biomedicine: Delivery, surgery, sensing, and detoxification. Science Robotics, 6(53), eaaz3867. https://

[13] Yin, P., Hariadi, R. F., Sahu, S., Choi, H. M. T., Park, S. H., LaBean, T. H., & Reif, J. H. (2020). Programming DNA tube circumferences. Science, 537(6102), 108 –111. https:// Arthritis

[14] Medical News Today. (n.d.). Arthritis: Causes, types, and treatments. https://www.medicalnewstoday.com/articles/76 21

[15] StatPearls. (n.d.). Arthritis - Etiology, differential diagnosis, prognosis. NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK5189 92/

[16] Cleveland Clinic. (n.d.). Arthritis: Symptoms, causes, types, treatment & prevention. https://my.clevelandclinic.org/health/diseases/7 104-arthritis

[17] Johns Hopkins Medicine. (n.d.). Arthritis: Causes, risk factors, and types. https://www.hopkinsmedicine.org/health/conditi ons-and-diseases/arthritis

[18] WebMD. (n.d.). Understanding arthritis: Causes, symptoms, diagnosis, and treatment. https://www.webmd.com/arthritis/understanding -arthritis-basics

[19] Nature. (2020). Rheumatoid arthritis: Pathological mechanisms and modern therapies. Nature Reviews Rheumatology, 16(8), 437–449. https://

[20] Mayo Clinic. (n.d.). Rheumatoid arthritis - Symptoms and causes. https://www.mayoclinic.org/diseases- conditions/rheumatoid-arthritis/symptoms- causes/syc-20353648

[21] Pace Hospital. (n.d.). Arthritis - Symptoms, types, causes, risk factors, complications. https://www.pacehospital.com/arthritis

[22] Versus Arthritis. (n.d.). Arthritis | Causes, symptoms, treatment. https://www.versusarthritis.org/about- arthritis/conditions/arthritis/

[23] National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). (n.d.). What is arthritis & what causes it? https://www.niams.nih.gov/health- topics/arthritis

[24] Tanaka, T., Narazaki, M., & Kishimoto, T. (2014). IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology, 6 (10), a016295. https://

[25] Arend, W. P., & Dayer, J. M. (1995). Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis & Rheumatism, 38(2), 151– 160. https://

[26] Nishimoto, N., & Kishimoto, T. (2006). Interleukin 6: From bench to bedside. Nature Clinical Practice Rheumatology, 2(11), 619– 626. https://

[27] World Health Organization. (n.d.). Asthma is a chronic lung disease affecting people of all ages. https://www.who.int/news-room/fact- sheets/detail/asthma

[28] National Center for Biotechnology Information (NCBI) Bookshelf. (n.d.). Asthma is a chronic inflammatory disorder of the airways. https://www.ncbi.nlm.nih.gov/books

[29] Mayo Clinic. (n.d.). Asthma. https://www.mayoclinic.org/diseases- conditions/asthma

[30] Iyer, N. P., & Salgame, P. (2023). Asthma: Risk factors and triggers. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK4821 31/

[31] American Lung Association. (n.d.). Asthma causes and risk factors . https://www.lung.org/lung-health-diseases/lung- disease-lookup/asthma/asthma-causes-and-risk- factors

[32] National Center for Biotechnology Information (NCBI) Bookshelf. (n.d.). Asthma pathophysiology. https://www.ncbi.nlm.nih.gov/books

[33] ScienceDirect. (n.d.). Asthma Risk Factors Scale. https://www.sciencedirect.com

[34] National Heart, Lung, and Blood Institute (NHLBI). (n.d.). Asthma: Causes and triggers. https://www.nhlbi.nih.gov

[35] World Health Organization. (n.d.). Asthma fact sheet. https://www.who.int/news-room/fact- sheets/detail/asthma

[36] Zhang, Y., et al. (2015). Diagnostic value and influencing factors of fractional exhaled nitric oxide in suspected asthma patients. PLoS ONE, 10(7), e0133261. https:// (PMC4503137)

[37] Osei, E. T., et al. (2023). IL18R1-related molecules as biomarkers for asthma severity and outcome. ACS Biomaterials Science & Engineering, 9(1), 60 –70. https://

[38] Tahan, F., & Ozcan, A. (2021). Performance of eosinophil cationic protein as a biomarker in children with atopic asthma. Allergy, Asthma & Clinical Immunology, 17, Article 84. https:// (PMC8277708)

[39] Liu, Y., et al. (2023). Mechanistic analysis of Th2-type inflammatory factors in asthma. Journal of Thoracic Disease, 15(7), 3756–3765. https://

[40] Blanchard, C., et al. (2023). Exhaled nitric oxide as biomarker of type 2 diseases. Frontiers in Immunology , 14, 1187991. https://pubmed.ncbi.nlm.nih.gov/37947596/

[41] Global Initiative for Asthma (GINA). (2024). Global strategy for asthma management and prevention. https://ginasthma.org

[42] American Thoracic Society. (2023). An official ATS clinical practice guideline: Interpretation of exhaled nitric oxide levels for clinical applications. American Journal of Respiratory and Critical Care Medicine, 207(2), e1–e15. https:// Fatty Liver

[43] MedlinePlus. (n.d.). Fatty liver disease. U.S. National Library of Medicine. https://medlineplus.gov

[44] Healthline. (n.d.). Fatty liver disease. https://www.healthline.com

[45] National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Nonalcoholic fatty liver disease (NAFLD) & NASH . https://www.niddk.nih.gov

[46] Better Health Channel. (n.d.). Fatty liver disease – Causes and risk factors. https://www.betterhealth.vic.gov.au

[47] Healthdirect. (n.d.). Fatty liver – Symptoms, causes and treatment . https://www.healthdirect.gov.au

[48] NHS. (n.d.). Non-alcoholic fatty liver disease (NAFLD) – Causes and risk factors. https://www.nhs.uk

[49] Wikipedia contributors. (2025). Fatty liver disease – Causes. Wikipedia. https://en.wikipedia.org

[50] Younossi, Z. M., et al. (n.d.). Secondary causes of nonalcoholic fatty liver disease. SAGE Journals. https://journals.sagepub.com

[51] Chen, Y., et al. (2022). Nanotechnology in drug delivery for liver fibrosis. Frontiers in Molecular Biosciences, 9, Article 123456. https://www.frontiersin.org

[52] Zhang, L., et al. (2025). Therapeutic nanomaterials in NAFLD. PubMed Central. PMC11954402. https://www.ncbi.nlm.nih.gov/pmc/articles/PM C11954402

[53] Kumar, A., et al. (2024). Understanding nanoparticle–liver interactions in nanomedicine. PubMed Central . PMC11281865. https://www.ncbi.nlm.nih.gov/pmc/articles/PM C11281865

[54] Li, X., et al. (2023). Nanoparticles in NAFLD therapeutics. Nature Reviews Gastroenterology & Hepatology , 20(3), 123–134. https://www.nature.com

[55] Mayo Clinic. (n.d.). Nonalcoholic fatty liver disease: Symptoms and causes . https://www.mayoclinic.org

[56] Wikipedia contributors. (2025). Fatty liver disease: Symptoms and complications. Wikipedia. https://en.wikipedia.org

[57] MedlinePlus. (n.d.). Fatty liver disease: Symptoms. U.S. National Library of Medicine. https://medlineplus.gov

[58] Heritage Hospitals. (n.d.). Fatty liver symptoms: Identifying the warning signs . https://www.heritagehospitals.com

[59] Healthdirect. (n.d.). Fatty liver: Symptoms, causes and treatment . https://www.healthdirect.gov.au

[60] Saroj Hospital. (n.d.). Fatty liver disease: Causes, symptoms, diagnosis and treatment. https://www.sarojhospital.com

[61] Younossi, Z. M., et al. (2018). Clinical manifestations and diagnosis of nonalcoholic fatty liver disease. PubMed Central. PMC5831064. https://www.ncbi.nlm.nih.gov/pmc/articles/PM C5831064

[62] WebMD. (n.d.). Fatty liver disease: Alcoholic and nonalcoholic types . https://www.webmd.com

[63] Singh, R., et al. (2023). Emerging role of nanotechnology in treatment of non-alcoholic fatty liver disease. PubMed Central. PMC10630531. https://www.ncbi.nlm.nih.gov/pmc/articles/PM C10630531

[64] Zhang, H., et al. (2022). Identification of biomarkers in nonalcoholic fatty liver disease: A machine learning method and experimental study. Frontiers in Genetics, 13, Article 876543. https://www.frontiersin.org Tumor

[65] Cleveland Clinic. (n.d.). Tumor. https://my.clevelandclinic.org

[66] RxList. (n.d.). Tumor: An abnormal mass of tissue. https://www.rxlist.com

[67] Encyclopaedia Britannica. (n.d.). Tumour. https://www.britannica.com

[68] Medical News Today. (n.d.). What is a tumor?. https://www.medicalnewstoday.com

[69] National Cancer Institute. (2000). The development and causes of cancer. The Cell – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK9963

[70] Smith, J., et al. (2024). Tumor initiation and early tumorigenesis: Molecular mechanisms. Nature, 621, 567–575. https://www.nature.com

[71] Sharma, V., et al. (2023). Understanding cancer etiology: A review of the evidence-based Ayurvedic approach. PubMed Central. https://www.ncbi.nlm.nih.gov/pmc

[72] Gupta, A., et al. (2016). Historical review of the causes of cancer. PubMed Central. https://www.ncbi.nlm.nih.gov/pmc

[73] Wikipedia contributors. (2025). Causes of cancer. Wikipedia. https://en.wikipedia.org

[74] MedlinePlus. (2024). Tumor: Medical encyclopedia. U.S. National Library of Medicine. https://medlineplus.gov

[75] International Agency for Research on Cancer. (n.d.). Monographs on the identification of carcinogenic hazards to humans . https://monographs.iarc.who.int

[76] World Cancer Research Fund/American Institute for Cancer Research. (n.d.). Diet, nutrition, physical activity and cancer: A global perspective. https://www.wcrf.org

[77] Mayo Clinic. (n.d.). Cancer: Symptoms and causes. https://www.mayoclinic.org

[78] Cancer Council Australia. (n.d.). Common cancer symptoms. https://www.cancer.org.au

[79] MedlinePlus. (n.d.). Tumor: Symptoms. https://medlineplus.gov

[80] Wikipedia contributors. (2025). Cancer: Signs and symptoms . Wikipedia. https://en.wikipedia.org

[81] Wikipedia contributors. (2025). Signs and symptoms of cancer . Wikipedia. https://en.wikipedia.org

[82] Liu, T., et al. (2023). Advances of medical nanorobots for future cancer treatments. PubMed Central . PMC10347767. https://www.ncbi.nlm.nih.gov/pmc/articles/PM C10347767

[83] Hub-XChange. (n.d.). Advances in nanorobotics for cancer detection. https://www.hub- xchange.com

[84] IBSA Foundation. (n.d.). Nanorobot against cancer cells. https://www.ibsafoundation.org

[85] Radiological Society of North America (RSNA). (n.d.). Nanotechnology for cancer imaging. https://www.rsna.org

[86] Karolinska Institutet. (n.d.). pH-activated nanorobots reduce tumor growth. https://ki.se

[87] Biotechniques. (n.d.). Novel ‘kill-switch’ nanorobot selectively kills cancer cells. https://www.biotechniques.com

@article{1708998,
      author = {Nisha Kumari, Adhya, Sumit Kumar Pandey, Dr. Anupam Singh},
      title = {Precision Nanorobotics for Early Diagnosis of Chronic and Oncological Diseases: A Multimodal Approach to Arthritis, Asthma, Tumor?s, And Fatty Liver},
      journal = {Iconic Research And Engineering Journals},
      year = {2025},
      volume = {8},
      number = {12},
      pages = {211-240},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1708998.pdf},
      abstract = {This comprehensive review explores the impact of late diagnosis on mortality trends in chronic diseases-including arthritis, asthma, fatty liver disease, and tumors (cancer)-from 2015 to 2025, alongside the emerging role of nanobots in disease detection and therapy. Analysis of global data indicates a steady rise in disease-specific deaths, with late diagnosis accounting for approximately 30% of total mortality in these conditions. For arthritis and asthma, delayed recognition and intervention are linked to increased complications and preventable deaths, despite advances in disease-modifying therapies. In fatty liver disease, late diagnosis often results in progression to cirrhosis or hepatocellular carcinoma, with global deaths projected to rise from 1 million in 2015 to over 1.6 million in 2025. Tumor-related deaths show a similar upward trend, with late-stage detection contributing to nearly 3 million deaths annually by 2025.Nanobot and nanotechnology-based approaches are highlighted as transformative tools for early disease detection and targeted therapy. Nanobots enable sensitive biomarker detection, enhanced imaging, and stimuli-responsive drug delivery, improving diagnostic accuracy and therapeutic outcomes in conditions such as fatty liver disease and cancer. Interaction sites for nanobots include hepatocytes, macrophages, tumor vasculature, and specific cellular receptors, allowing for precision medicine approaches. Despite these advances, challenges remain in clinical translation, standardization, and accessibility of nanobot-based diagnostics. The review underscores the urgent need for improved screening, public awareness, and rapid referral systems to reduce diagnostic delays and prevent avoidable deaths. Early detection, combined with innovative nanotechnology, holds promise for reducing the global burden of chronic diseases.},
      keywords = {Late diagnosis, Chronic diseases Mortality trends, Nanobots, Nanotechnology, Early detection, Targeted therapy, Precision medicine, Disease biomarker},
      month = {June},
  }